TRACER
1 known investors
TRACER is a contract research organization (CRO) that runs Phase 0 first-in-human clinical trials using nuclear and optical molecular imaging, labeling drug developers' compounds (antibodies, small molecules, peptides, nanoparticles, proteins) with fluorescent dyes or radionuclides. It provides imaging and clinical services to help sponsors make early go/no-go decisions on lead compounds through microdosing before Phase 1-3 development.
BiotechDigital HealthMedical Devices
Investors · 1
Frequently asked questions
- What does TRACER do?
- TRACER is a contract research organization (CRO) that runs Phase 0 first-in-human clinical trials using nuclear and optical molecular imaging, labeling drug developers' compounds (antibodies, small molecules, peptides, nanoparticles, proteins) with fluorescent dyes or radionuclides. It provides imaging and clinical services to help sponsors make early go/no-go decisions on lead compounds through microdosing before Phase 1-3 development.
- Who are TRACER's investors?
- TRACER's investors include NV NOM.